Clinical trial
Preoperative Concurrent Chemoradiotherapy Combined With Nimotuzumab Injection for Locally Advanced Cervical Cancer: a Phase II Study
NCT01938105 is registered in ClinicalTrials.gov with People's Hospital of Guangxi Zhuang Autonomous Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Concurrent Chemoradiotherapy Combined With Nimotuzumab Injection for Locally Advanced Cervical Cancer: a Phase II Study
- Lead sponsor
- People's Hospital of Guangxi Zhuang Autonomous Region
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- June 30, 2016
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced cervical cancer